Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy
β Scribed by RICHARD HALLINAN; ANDREW BYRNE; JANAKI AMIN; GREGORY J DORE
- Book ID
- 108950337
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 64 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract While much is known about hepatitis C virus (HCV) among injecting drug users (IDUs), there is scant information about the risk of HCV infection to nonβinjecting sexual partners of injecting drug users; it is possible that such individuals may have a greater risk of acquiring HCV than an
## Abstract Nonβinjecting drug users are at highβrisk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of nonβinjecting dru
An RT-PCR assay using primers from the 5Π-UTR of the GBV-C/HGV genome was used to detect viremia, and a serological assay was used to detect past exposure to GBV-C/HGV, in sera from 106 imprisoned Greek intravenous drug users. High seroprevalence rates indicative of the parenteral route of transmiss